Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of vildagliptin, an
unapproved drug, compared to placebo in lowering post-meal blood glucose levels in people
with pre-diabetes who have high blood sugar levels after meals.